Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,238.00    -18.00 (-1.43%)
Bid:
1,232.00
Ask:
1,238.00
Spread: 6.00 (0.487%)
Market Cap: £567.33m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Win

1 Apr 2022 07:00

RNS Number : 8672G
Cohort PLC
01 April 2022
Β 

One Waterside Drive

Arlington Business Park

Reading

Berks

RG7 4SW

Β 

Β 

Β 

1st April 2022

Β 

Β 

Β 

Β 

Β 

Β 

Β 

COHORT PLC

("Cohort" or "the Group")

CONTRACT WIN

Β 

MCL RECEIVES Β£12 MILLION IN ORDERS FROM UK MOD

Β 

Β 

Cohort plc, the AIM listed technology group, is pleased to announce that its subsidiary Marlborough Communications Limited (MCL) has received two orders from the UK Ministry of Defence (MOD) for its long-term partner INVISIO's hearing protection and communication ancillaries, for use on armoured fighting vehicles and in dismounted close combat, one of the most demanding and challenging noise environments within the UK military. Deliveries commence in the second half of 2022 through to mid-2023.

Β 

The first order, which is valued at over Β£9 million, is for the INVISIO V-Series Gen II platform for use on armoured fighting vehicles. The solution offers the user efficient communication and unique dual hearing protection by combining the in-service INVISIO X5 in-the-ear headset and its T7 over-the-ear headset, which both connect to the INVISIO V60 control unit.

Β 

The second order is for further deliveries of INVISIO's Tactical Hearing Protection System Dismounted Close Combat Users program (THPS DCCU). The THPS DCCU provides superior hearing protection and enhanced situational awareness for dismounted close combat personnel.

Β 

Andy Thomis, Cohort Chief Executive said, "These orders are a clear demonstration of the strength of the 10-year partnership and collaboration between MCL and INVISIO, and further cement MCL's position as the MOD's leading supplier of innovative hearing protection systems, to protect UK military personnel. Together with other recent contract wins across the Group, these orders further strengthen our order book and enhance the visibility of future revenues."

Β 

For further information on MCL, please visit: marlboroughcomms.com

For further information on Cohort plc please visit: cohortplc.comΒ 

Β 

ENDS

Β 

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

Simon Walther, Finance Director

Raquel McGrath, Company Secretary

020 7597 5970

Investec Bank Plc (NOMAD and Broker)

Daniel Adams, Christopher Baird

MHP Communications

020 3128 8570

Reg Hoare, Pete Lambie

cohort@mhpc.com

Β 

Β 

Β 

NOTES TO EDITORS

Β 

Cohort plc (www.cohortplc.com) is the parent company of six innovative, agile and responsive businesses based in the UK, Germany and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

Β 

Chess offers surveillance, tracking and fire-control systems to the defence and security markets. A majority stake was acquired by Cohort plc in December 2018. www.chess-dynamics.com

Β 

EID designs and manufactures advanced communications systems for naval and military customers. Cohort acquired a majority stake in June 2016. www.eid.pt

Β 

ELAC SONAR supplies advanced sonar systems and underwater communications to global customers in the naval marketplace. Acquired by Cohort in December 2020. www.elac-sonar.deΒ 

Β 

MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services and training support. Acquired by Cohort in August 2006.Β www.mass.co.uk

Β 

MCL designs, sources and supports advanced electronic and surveillance technology for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014.Β www.marlboroughcomms.com

Β 

SEA delivers and supports technology-based products for the defence and transport markets alongside specialist research and training services.Β Acquired by Cohort in October 2007.Β www.sea.co.uk

Β 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has headquarters in Reading, Berkshire and employs in total around 1,000 core staff there and at its main operating company sites across the UK, Germany and Portugal.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
CNTBKDBBDBKBANN
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.